Source: International Congress 2019 – Pleural disease: applying the evidence
Disease area: Respiratory infections, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Iqbal (Peshawar, Pakistan), M. Khan (Peshawar, Pakistan), M. Khan (Peshawar, Pakistan), Z. Ullah (Peshawar, Pakistan). Role of Biomarkers for Predicting suspecting Malignant Mesothelioma in patients with Pleural Effusion presenting to a tertiary care hospital. 3091

Member's Comments

No comment yet.

Related content which might interest you: Management of recurrent Malignant Pleural Effusion: what is the best method? Source: ERS Course 2015 Year: 2015 Management of recurrent Malignant Pleural Effusion: what is the best method? Source: School Course 2014 - Thoracoscopy and Pleural Techniques Year: 2014 The role of a pleural service in optimising pleural disease management Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Pleural mesothelioma: Our experience in 132 cases Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Role of fibulin-3 in the diagnosis of malignant mesothelioma Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Validity of Pleural Fluid Protein in differentiating Tuberculous from Malignant Pleural Effusion Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019 Etiology of pleural effusions in a general hospital Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Pericardiodesis in pericardial tamponade Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Pleural effusion in a pediatric hospital: epidemiologycal characteristics Source: Eur Respir J 2007; 30: Suppl. 51, 390s Year: 2007 Haematologic parameters and their prognostic impact in malignant pleural mesothelioma Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Malignant pleural mesothelioma: A retrospective analysis of 32 cases Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Malignant mesothelioma diagnosed at medical thoracoscopy – A service review Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Pleural effusions after cardiac surgery: Etiology and outcomes Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016 Laboratorial spectrum of pleural effusions in a tertiary hospital - Five years analysis Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Thoracoscopy: Outcomes in non-diagnostic procedures Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Role of Indwelling Pleural Catheters in acheiving spontaneous pleurodesis in Hepatic Hydrothorax - Pioneer Retrospective Study from a Tertiary care centre,India Source: Virtual Congress 2020 – Interventional pulmonology: unity in diversity Year: 2020 Comparison of multiple serum and pleural fluid biomarkers for the diagnosis of Malignant Pleural Mesothelioma Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Pleural complicationsin patients with chronic and end-stage renal disease Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014